Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1530, 2006-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Exemestane: clinical benefits without QOL compromise
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 499, 2006-01 ,pp. :
Access to resources
Recommend
New trimetazidine formulation benefits clinical, QOL status
Inpharma, Vol. 1, Iss. 1471, 2005-01 ,pp. :
Natalizumab shows clinical, cost and QOL benefits
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 514, 2006-01 ,pp. :
New trimetazidine formulation benefits clinical, QOL status
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 469, 2005-01 ,pp. :
Exemestane and tamoxifen both improve QOL
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 649, 2012-01 ,pp. :